Title:
PHARMACEUTICAL COMPOSITION CONTAINING CERIUM COMPOUND AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2022/014122
Kind Code:
A1
Abstract:
The primary problem of the present invention is to provide a novel pharmaceutical composition. The present invention relates to a pharmaceutical composition containing a cerium compound as an active ingredient.
Inventors:
KAWAGUCHI TSUNETAKA (JP)
NAKATSU MASAHARU (JP)
OGAWA YUKIHIRO (JP)
HASHIMOTO AKIKO (JP)
NAKATSU MASAHARU (JP)
OGAWA YUKIHIRO (JP)
HASHIMOTO AKIKO (JP)
Application Number:
PCT/JP2021/017295
Publication Date:
January 20, 2022
Filing Date:
April 30, 2021
Export Citation:
Assignee:
KAWAGUCHI TSUNETAKA (JP)
International Classes:
A61K33/244; A61K9/51; A61K47/12; A61K47/18; A61K47/32; A61P7/08; A61P13/12; C01F17/235
Foreign References:
| JP2020045291A | 2020-03-26 | |||
| JP2020045290A | 2020-03-26 | |||
| JP2016514163A | 2016-05-19 | |||
| JP2018508568A | 2018-03-29 | |||
| JP2007022836A | 2007-02-01 | |||
| JPS6211611B2 | 1987-03-13 | |||
| JPH11503119A | 1999-03-23 | |||
| JPS614529A | 1986-01-10 |
Other References:
OGURA MITSUO, HITOSHI IWAMOTO, TAKASHI AKIBA, SEINOSUKE NAKAGAWA: "Development of non-aluminum phosphate binder - Hydrous cerium oxide ", JOURNAL OF ARTIFICIAL ORGANS, vol. 15, no. 3, 1 January 1986 (1986-01-01), pages 775 - 778, XP055898169
SAIFI, M. A. ET AL.: "Protective Effect of Nanoceria on Cisplatin-induced Nephrotoxicity by Amelioration of Oxidative Stress and Pro- inflammatory Mechanisms", BIOLOGICAL TRACE ELEMENT RESEARCH, vol. 189, 2019, pages 145 - 156, XP036747226, DOI: 10.1007/s12011-018-1457-0
MIYAKAWA, KAZUKI ET AL.: "XC237 Ce02 nanoparticle hydrothermal synthesis with amino base for the production of nanocomposite materials", SCEJ 80TH ANNUAL MEETING; TOKYO, JAPAN; MARCH 19-21, 2015, vol. 80, 30 November 2014 (2014-11-30) - 21 March 2015 (2015-03-21), JP, pages XC237, XP009534214
TOSHIMITSU NIWATAKASHI MIYAZAKI: "Current State of Uremic Substance Research '98 - from the 43rd Current Concept of the Japanese Society for Dialysis Therapy", JOURNAL OF JAPANESE SOCIETY FOR DIALYSIS THERAPY, vol. 31, no. 12, 1998, pages 1423 - 1429
MASAYA IWAMUROHIROMITSU KANZAKISEIJI KAWANOYOSHIRO KAWAHARATAKEHIRO TANAKAHIROYUKI OKADA: "Endoscopic Features of Lanthanum Deposition in the Gastroduodenal Mucosa", GASTROENTEROL ENDOSC., vol. 59, no. 6, 2017, pages 1428 - 1434
MUNEHIRO YOSHIDAISSEI NISHIZAKIEMI KOMURARYOTA HOSAMIKENJI FUKUNAGA: "Effect of difference in dietary protein on serum phosphorus and tissue lanthanum concentration in rats administered lanthanum carbonate", TRACE NUTRIENTS RESEARCH, vol. 36, 2019, pages 29 - 34
SAIFI, M. A. ET AL.: "Protective Effect of Nanoceria on Cisplatin-induced Nephrotoxicity by Amelioration of Oxidative Stress and Pro- inflammatory Mechanisms", BIOLOGICAL TRACE ELEMENT RESEARCH, vol. 189, 2019, pages 145 - 156, XP036747226, DOI: 10.1007/s12011-018-1457-0
MIYAKAWA, KAZUKI ET AL.: "XC237 Ce02 nanoparticle hydrothermal synthesis with amino base for the production of nanocomposite materials", SCEJ 80TH ANNUAL MEETING; TOKYO, JAPAN; MARCH 19-21, 2015, vol. 80, 30 November 2014 (2014-11-30) - 21 March 2015 (2015-03-21), JP, pages XC237, XP009534214
TOSHIMITSU NIWATAKASHI MIYAZAKI: "Current State of Uremic Substance Research '98 - from the 43rd Current Concept of the Japanese Society for Dialysis Therapy", JOURNAL OF JAPANESE SOCIETY FOR DIALYSIS THERAPY, vol. 31, no. 12, 1998, pages 1423 - 1429
MASAYA IWAMUROHIROMITSU KANZAKISEIJI KAWANOYOSHIRO KAWAHARATAKEHIRO TANAKAHIROYUKI OKADA: "Endoscopic Features of Lanthanum Deposition in the Gastroduodenal Mucosa", GASTROENTEROL ENDOSC., vol. 59, no. 6, 2017, pages 1428 - 1434
MUNEHIRO YOSHIDAISSEI NISHIZAKIEMI KOMURARYOTA HOSAMIKENJI FUKUNAGA: "Effect of difference in dietary protein on serum phosphorus and tissue lanthanum concentration in rats administered lanthanum carbonate", TRACE NUTRIENTS RESEARCH, vol. 36, 2019, pages 29 - 34
Attorney, Agent or Firm:
TSUJITA, Tomoko (JP)
Download PDF: